Cardioprotective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts

Transplantation

Volumn 61, Issue 7, 1996, Pages 1023-1028

  Duguay, Pierre ^a   Chen, Huifang ^a,b   Daloze, Pierre ^a,b   Dumont, Louis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 AMINOSTEROID; BRADYKININ; LAZAROID; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CRYOPRESERVATION; GRAFT PRESERVATION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HEART TRANSPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BRADYKININ; COLD; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FREE RADICALS; HEART; HEART TRANSPLANTATION; MALE; ORGAN PRESERVATION; PREGNATRIENES; RATS; RATS, INBRED LEW;

EID: 0029935652     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00007     Document Type: Article

References (57)

1. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673.
2. Stein DG, Drinkwater DC Jr, Laks H, et al. Cardiac preservation in patients undergoing transplantation. J Thorac Cardiovasc Surg 1991; 102: 657.
3. Kaye MP. The registry of the International Society for Heart and Lung Transplantation: official report 1993. J Heart Lung Transplant 1993; 12: 541.
4. Nillson FN, Miller VM, Vanhoutte PM, McGregor CGA. Methods of cardiac preservation alter the function of the endothelium in porcine coronary arteries. J Thorac Cardiovasc Surg 1991; 102: 923.
5. Cartier R, Dagenais F, Hollman C, Carrier M, Pelletier LC. The role of preservation solutions in coronary endothelial damage during cold storage. Transplantation 1993; 56: 997.
6. Pearl JM, Laks H, Drinkwater DC, et al. Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. J Thorac Cardiovasc Surg 1994; 107: 257.
7. Galinanes M, Bullough D, Mullane KM, Hearse DJ. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation 1992; 86: 589.
8. Pinsky Q, Oz M, Liao H, et al. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model. J Clin Invest 1993; 92: 2994.
9. Hess ML, Manson NH. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 1984; 16: 969.
10. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757.
11. Burton KP. Evidence of direct toxic effects of free radicals on the myocardium. Free Radic Biol Med 1988; 4: 15.
12. Stewart JR, Gerhardt EB, Wehr CJ, et al. Free radical scavengers and myocardial preservation during transplantation. Ann Thorac Surg 1986; 42: 390.
13. Gharagozloo F, Melendez FJ, Hein RA, Shenin RJ, DiSesa VJ, Cohn LH. The effect of superoxide dismutase and catalase on the extended preservation of the ex vivo heart for transplantation. J Thorac Cardiovasc Surg 1988; 95: 1008.
14. Jurmann MJ, Schaefers HJ, Dammenhayn L, Haverich A. Oxygen-derived free radical scavengers for amelioration of reperfusion damage in heart transplantation. J Thorac Cardiovasc Surg 1988; 95: 368.
15. Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhinpenko YN. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982; 77: 465.
16. Rao PS, Cohen MV, Mueller HS. Production of free radicals and lipid peroxidation in early experimental myocardial ischemia. J Mol Cell Cardiol 1983; 15: 713.
17. Ambrosio G, Flaherty JT, Duillio C, et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991; 87: 2056.
18. Pickford MA, Gower JD, Doré C, Fryer PR, Green CJ. Lipid peroxidation and ultrastructural changes in rat lung isografts after single-passage organ flush and 48-hour cold storage with and without one-hour reperfusion in vivo. Transplantation 1990; 144: 210.
19. Manciet LH, Copeland JG. Lipid peroxidation results in compromised functional recovery of isolated rabbit hearts after low-pressure, hypothermic, perfused preservation for 24 hours. J Thorac Cardiovasc Surg 1992; 103: 532.
20. Braughler JM, Pregenzer JM, Chase RL, Duncan LA, Jacobson EJ, McCall JM. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262: 10438.
21. Braughler JM, Pregenzer JF. The aminosteroid inhibitors of lipid peroxidation reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med 1989; 7: 125.
22. Canadian Council on Animal Care. Guide to the care and use of experimental animals, Vol 1, 2nd ed. Ottawa: Canadian Council on Animal Care, 1993.
23. Ono K, Lindsey E. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
24. Dumont L, Chen HF, Daloze P, Xu D, Garceau D. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation. Transplantation 1993; 56: 181.
25. Romaschin AD, Rebeyka I, Wilson GF, Mickle DAG. Conjugated dienes in ischemic and reperfused myocardium: an in vivo chemical signature of oxygen free radicals mediated injury. J Mol Cell Cardiol 1987; 19: 289.
26. Prasad NR, Das DK. Effect of oxygen-derived free radicals and oxidants on the degradation in vitro of membrane phospholipids. Free Radic Res Commun 1989; 7: 381.
27. Parks, DA, Bulkley GB, Granger DN. Role of oxygen free radicals in shock, ischemia, and organ preservation. Surgery 1983; 94: 428.
28. Green CJ, Healing G, Lunec J, Fuller BJ, Simpkin S. Evidence of free radical induced damage in rabbit kidney after simple hypothermic preservation and autotransplantation. Transplantation 1986; 41: 161.
29. Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Rad Biol Med 1989; 7: 45.
30. Klein HH, Pich S, Lindert S, Nebendahl K, Niedman P, Kreuzer H. Combined treatment with vitamin E and C in experimental myocardial infarction in pigs. Am Heart J 1989; 4: 667.
31. Koerner JE, Anderson BA, Dage RC. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals superoxide dismutase plus catalase, N-2-mercaptoproprionyl glycine and captopril. J Cardiovasc Pharmacol 1991; 17: 185.
32. 10 of canine myocardial reperfusion injury after preservation. J Thorac Cardiovasc Surg 1992; 103: 45.
33. Pietri S, Culcasi M, Albat B, Albérici G, Menasché P. Direct assessment of the antioxidant effects of a new heart preservation solution, celsior. Transplantation 1994; 58: 739.
34. McCall JM, Braughler JM, Hall ED. A new class of compounds for stroke and trauma: effects of 21-aminosteroids on lipid peroxidation. Acta Anaesth Belg 1987; 38: 417.
35. Braughler JM, Burton PS, Chase RL, et al. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochem Pharmacol 1988; 37: 3853.
36. Jacobsen EJ, McCall JM, Ayer DE, et al. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma. J Med Chem 1990; 33: 1145.
37. Hall ED, Berry KP, Braughler JM. U74006F, a novel 21-aminosteroid inhibitor of lipid peroxidation, attenuates neuronal necrosis and promotes post-ischemia survival in the gerbil. Stroke 1988; 19: 991.
38. Zuccarello M, Anderson DK. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 1989; 29: 367.
39. Natale JE, Schott RJ, Hall ED, Braughler JM, d'Alecy LG. Effects of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988; 19: 1371.
40. Aoki N, Lefer AM. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats. J Cardiovasc Pharmacol 1990; 15: 205.
41. Cosenza CA, Cramer DV, Cunneen SA, et al. Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 1994; 19: 418.
42. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
43. Salem Y, Dulchavsky SA, Dutta S, Diebel LN. Effect of inhibition of lipid peroxidation on myocardial oxidant damage. J Surg Res 1994; 56: 606.
44. Lindal S, Myklebust R, Sorlie D, Jorgensen L. Morphological changes in atrial myocardial cells after cold cardioplegia standstill and during reperfusion in coronary bypass surgery. Scand J Thorac Cardiovasc Surg 1983; 17: 109.
45. Fremes SE, Weisel RD, Mickle DAG, et al. Myocardial metabolism and ventricular function following cold potassium cardioplegia. J Thorac Cardiovasc Surg 1985; 89: 531.
46. Selke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 1993; 105: 52.
47. Holzgrefe HH, Buchanan LV, Gibson JK. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J Cardiovasc Pharmacol 1990; 18: 239.
48. Carrea FP, Lesnefsky EJ, Kaiser DG, Horwitz LD. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J Cardiovasc Pharmacol 1992; 20: 230.
49. Levitt MA. Sievers RE, Wolfe CL. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid. J Cardiovasc Pharmacol 1994; 23: 136.
50. Ovize M, de Lorgelil M, Ovize A, et al. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion. Am Heart J 1991; 122: 681.
51. Hendry PJ, Anstadt MP, Plunkett MD, et al. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant 1992; 11: 636.
52. Saldanha C, Hearse DJ. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. J Thorac Cardiovasc Surg 1989; 98: 783.
53. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991; 83: 2048.
54. Seccombe JF, Pearson PJ, Schaff HV. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg 1994; 107: 505.
55. Bando K, Tago M, Teramoto S. Prevention of free radical-induced myocardial injury by allopurinol: experimental study in cardiac preservation and transplantation. J Thorac Cardiovasc Surg 1988; 95: 368.
56. Zweier JL, Kuppusamy P, Williams R, et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 1989; 264: 18890.
57. Ferrari R, Ceconi C, Cargnoni A, De Giuli F, Visioli O. Occurrence of oxidative stress during myocardial reperfusion. Mol Cell Biochem 1992; 3: 61.